000 01363nam a2200373 a 4500
005 20250918124753.0
006 m o d
007 cr nn 008maaau
008 101230s2010 nju s j eng d
020 _a9781603272711 (electronic bk.)
020 _a9781603272704 (paper)
035 _a(Springer)978-1-60327-270-4
039 9 _y12-30-2010
_zmuhaimin
050 0 4 _aRC270.8
_b.M76 2010
082 0 4 _a616.99406
_222
090 _aRC270.8
_b.M939 2010
245 0 0 _amTOR pathway and mTOR inhibitors in cancer therapy
_h[electronic resource] /
_cedited by Vitaly A. Polunovsky, Peter J. Houghton.
250 _aFirst.
260 _aTotowa, NJ :
_bSpringer Science+Business Media, LLC,
_c2010.
300 _axii, 301 p. :
_bill., digital ;
_c24 cm.
440 0 _aCancer drug discovery and development
650 0 _aCancer
_xTreatment.
700 1 _aPolunovsky, Vitaly A.
700 1 _aHoughton, Peter J.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
856 4 0 _uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=http://dx.doi.org/10.1007/978-1-60327-271-1
907 _a.b14900622
_b2023-12-12
_c2019-11-12
942 _n0
_kRC270.8 .M939 2010
914 _avtls003451814
998 _ae0001
_b2010-04-12
_cm
_dz
_feng
_gnju
_y0
_z.b14900622
999 _c476622
_d476622